NEW YORK, Sept. 27 - A wholly owned subsidiary of Deltagen will create a new research and development center in Strasbourg, France, in a move designed to strengthen the company’s research presence on the continent, Deltagen said on Thursday. 

The unit, Deltagen Europe, said it chose the new location because of its proximity to the Institut de Genetique et de Biologie Moleculaire et Cellulaire, with which Deltagen has a “close research partnership.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.